Promoting Crocs’ Croslite material as “patented” misled consumers into believing that the material of competing footwear was ...
Tharimmune, Inc. (NASDAQ:THAR) (”Tharimmune” or the “Company”), a clinical-stage biotechnology company developing a portfolio of therapeutic candidates in inflammation and immunology, announced today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback